Canopy Growth Corporation

WEED

CA1380351009

Pharmaceuticals

Delayed Toronto Stock Exchange Other stock markets 09:59:38 2023-12-11 am EST			5-day change	1st Jan Change
1.045 ^CAD	-2.34%		+3.96%	-66.56%

Dec. 01	Canopy Growth Gains 4% As Closes Sale Of BioSteel Business For $30.4 Million	MT
Dec. 01	Canopy Growth Closes Sale Of BioSteel Business For $30.4 Million	MT

Official CANOPY GROWTH CORPORATION press release

Canadian Investment Regulatory Organization Trade Resumption - WEED

September 12, 2023 at 10:21 am EDT

TORONTO, Sept. 12, 2023 /CNW/ - Trading resumes in:

Company: Canopy Growth Corporation

TSX Symbol: WEED

All Issues: No

Resumption (ET): 10:00:14 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

Latest news about Canopy Growth Corporation

Canopy Growth Gains 4% As Closes Sale Of BioSteel Business For $30.4 Million	Dec. 01	MT
Canopy Growth Closes Sale Of BioSteel Business For $30.4 Million	Dec. 01	MT
Canopy Growth Brief: Completed Sale of BioSteel Business; Says Realization of sale proceeds further strengthens its balance sheet; Adds Completed transactions further advances its cannabis-focused, asset-light operating model	Dec. 01	MT
Canopy Growth Corporation Partners with Marquee Brands Partners and Martha Stewart CBD to Unveil New Line of Need-Based CBD Gummies	Nov. 29	CI
Canopy Growth Says Canadian Court Approved Sale of BioSteel Canada, BioSteel Manufacturing Assets	Nov. 17	MT
Canopy Growth Brief: Shares Now Flat In US Premarket, After Being Up 1.3%, Announcing that BioSteel Obtained Court Approval of Successful Bids in Sale and Investment Solicitation Process	Nov. 17	MT
Canopy Growth Up 1.3% In US Premarket Trade After Announcing that BioSteel Obtained Court Approval of Successful Bids in Sale and Investment Solicitation Process	Nov. 17	MT
Canopy Growth Brief: Announcing that BioSteel Obtained Court Approval of Successful Bids in Sale and Investment Solicitation Process	Nov. 17	MT
Canopy Growth Corporation Announces the Addition of Four New Flower Product Offerings from Iconic Brands 7ACRES and Tweed	Nov. 15	CI
Canopy Growth Brief: Announcing addition of four new flower product offerings "Just in time for the holiday season"	Nov. 15	MT
TSX futures slip on hawkish Fed remarks, lower metal prices	Nov. 10	RE
Transcript : Canopy Growth Corporation, Q2 2024 Earnings Call, Nov 09, 2023	Nov. 09	CI
Canopy Growth Up 9% After Hours as its Fiscal Q2 Loss Widens on Lower Sales	Nov. 09	MT
Canopy Growth Brief: Consolidated gross margin was 34% in Q2 FY2024, compared to (1%) in Q2 FY2023, primarily driven by "business transformation initiatives" executed since the beginning of FY2023	Nov. 09	MT
Canopy Growth Brief: Says Achieved Q2 FY2024 net revenue of $70 Million	Nov. 09	MT
Canopy Growth Brief: Reduced overall debt by $364 Million to $681 MM in Q2 FY2024; Total debt reduction of approximately $1 BN delivered since the beginning of FY2023	Nov. 09	MT
Canopy Growth Brief: Management reaffirms expectation to achieve positive Adjusted EBITDA in all business units exiting FY2024	Nov. 09	MT
Pot producer Canopy Growth's second-quarter core loss narrows	Nov. 09	RE
Canopy Growth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
North American Morning Briefing : Traders Await Powell Speech	Nov. 09	DJ
Canopy Growth Brief: Constellation Brands Announcing Expiration of Canopy Growth Warrants	Nov. 03	MT
Constellation Brands' 139.75-Million Canopy Growth Warrants Expire Without Being Exercised	Nov. 03	MT
Canopy Growth Price Target Raised to $0.50 at CIBC	Oct. 31	MT
Piper Sandler With Model Update On Canopy Growth To Classify Q2 FY24 BioSteel As Discontinued Operations	Oct. 30	MT
Health Care Up on Obesity-Drug Optimism -- Health Care Roundup	Oct. 10	DJ

Chart Canopy Growth Corporation

Duration

Period

More charts

Company Profile

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products with a focus on cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. It operates through four segments: Canada cannabis, Storz & Bickel, Rest-of-world cannabis, and This Works. Its CPG portfolio features targeted 24-hour skincare and wellness solutions from This Works, gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. The Storz & Bickel segment includes the production, distribution, and sale of vaporizers.

Sector

Pharmaceuticals

Calendar

2024-02-14 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Canopy Growth Corporation

Trading Rating :

Investor Rating :

ESG Refinitiv :

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

1.07CAD

Average target price

0.8669CAD

Spread / Average Target

-18.98%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
CANOPY GROWTH CORPORATION	-66.56%	653 M $
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.86%	5 809 M $
DONG-E-E-JIAO CO.,LTD.	+23.29%	4 511 M $
TASLY PHARMACEUTICAL GROUP CO., LTD	+53.44%	3 282 M $
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-16.52%	2 714 M $
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	+6.47%	1 976 M $
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-23.06%	1 833 M $
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+2.23%	1 721 M $
GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.	-3.92%	1 516 M $
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+30.21%	1 311 M $

Alternative Medicine

Canopy Growth Corporation

Equities

WEED

CA1380351009

Pharmaceuticals

Canadian Investment Regulatory Organization Trade Resumption - WEED

EPS Revisions